company
Zhejiang Huahai Pharmaceutical Co., Ltd.
Jurisdiction: US
FDA Warning Letter timeline
V1 scope: FDA Warning Letters only. Additional public-record sources (SEC, CPSC, federal contracts) are on the V2 roadmap and are not surfaced here today.
- fda_483 · inspection_citation2025-04-16Zhejiang Huahai Pharmaceutical Co., Ltd. -- FDA 483: 1 observation (2025-04-16)
- fda_483 · inspection_citation2024-11-20Zhejiang Huahai Pharmaceutical Co., Ltd. -- FDA 483: 4 observations (2024-11-20)
Frequently asked questions
- How many FDA warning letters has Zhejiang Huahai Pharmaceutical Co., Ltd. received?
- Argus HQ has not recorded an FDA warning letter for Zhejiang Huahai Pharmaceutical Co., Ltd. in our current dataset.
- What FDA recalls has Zhejiang Huahai Pharmaceutical Co., Ltd. issued?
- Argus HQ has not recorded an FDA recall tied to Zhejiang Huahai Pharmaceutical Co., Ltd. in our current dataset.
- Is Zhejiang Huahai Pharmaceutical Co., Ltd. FDA compliant?
- Argus HQ is not a compliance rating service. As of this page's last update, our dataset shows 0 warning letters, 0 recalls, and 0 approval records for Zhejiang Huahai Pharmaceutical Co., Ltd.. Review the linked FDA source records directly before drawing a compliance conclusion.
Informational only. FDA Warning Letters are public records (17 USC §105). Summaries are AI-assisted and may contain errors; always verify against the original FDA letter before acting. Not legal, financial, or regulatory advice.

